Patents by Inventor Ana Maria Ortiz Fernandez

Ana Maria Ortiz Fernandez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220326259
    Abstract: An in vitro method for diagnosing Alzheimer's disease (AD) includes determining the content of mercaptoalbumin (HMA) in a sample of cerebrospinal fluid (CSF), and comparing the content determined with the content of HMA in CSF in healthy subjects. If the HMA content is less than that of the healthy subjects, it is indicative of AD.
    Type: Application
    Filed: June 28, 2022
    Publication date: October 13, 2022
    Inventors: Salvador Grancha Gamon, Montserrat Costa Rierola, Ana Maria Ortiz Fernandez
  • Publication number: 20220073871
    Abstract: A composition is for improving the culture and implantation of mammalian embryos. The composition includes one or more of the fractions of human plasma fractionation using the Cohn method wherein in the composition human serum albumin (HSA) is between 90% and 96% of the total proteins in the composition, alfa and beta globulins are between 3.5% and 9.99% of the total proteins in the composition, and gamma globulin is between 0.01% and 0.5% of the total proteins in the composition.
    Type: Application
    Filed: February 12, 2020
    Publication date: March 10, 2022
    Inventors: Montserrat COSTA RIEROLA, Ana Maria ORTIZ FERNANDEZ, Samuel OJOSNEGROS MARTOS, Anna SERIOLA PETIT
  • Publication number: 20200141951
    Abstract: An in vitro method for diagnosing Alzheimer's disease (AD) includes determining the content of mercaptoalbumin (HMA) in a sample of cerebrospinal fluid (CSF), and comparing the content determined with the content of HMA in CSF in healthy subjects. If the HMA content is less than that of the healthy subjects, it is indicative of AD.
    Type: Application
    Filed: January 8, 2020
    Publication date: May 7, 2020
    Inventors: Salvador Grancha Gamon, Montserrat Costa Rierola, Ana Maria Ortiz Fernandez
  • Patent number: 10350274
    Abstract: A method prepares a solution of human albumin by reducing dissolved oxygen in a solution of albumin until a concentration of oxygen equal to or less than 0.5 ppm is achieved. A solution of human albumin having a redox state closer to the redox state of the albumin present in human plasma can be achieved.
    Type: Grant
    Filed: May 28, 2015
    Date of Patent: July 16, 2019
    Assignee: GRIFOLS, S.A.
    Inventors: Juan Ignacio Jorquera Nieto, Ana Maria Ortiz Fernandez, Montserrat Costa Rierola
  • Publication number: 20180136236
    Abstract: The present disclosure relates to an in vitro method for diagnosing Alzheimer's disease (AD), comprising the steps of: a) determining the content of mercaptoalbumin (HMA) in a sample of cerebrospinal fluid (CSF); and b) comparing the content determined with the content of HMA in CSF in healthy subjects. If the HMA content is less than that of the healthy subjects, it is indicative of AD.
    Type: Application
    Filed: November 6, 2017
    Publication date: May 17, 2018
    Applicant: GRIFOLS WORLDWIDE OPERATIONS LIMITED
    Inventors: Salvador Grancha Gamon, Montserrat Costa Rierola, Ana Maria Ortiz Fernandez
  • Publication number: 20170000855
    Abstract: A method prepares a solution of human albumin by reducing dissolved oxygen in a solution of albumin until a concentration of oxygen equal to or less than 0.5 ppm is achieved. A solution of human albumin having a redox state closer to the redox state of the albumin present in human plasma can be achieved.
    Type: Application
    Filed: May 28, 2015
    Publication date: January 5, 2017
    Inventors: Juan Ignacio Jorquera Nieto, Ana Maria Ortiz Fernandez, Montserrat Costa Rierola
  • Publication number: 20150343025
    Abstract: A method prepares a solution of human albumin by reducing dissolved oxygen in a solution of albumin until a concentration of oxygen equal to or less than 0.5 ppm is achieved. A solution of human albumin having a redox state closer to the redox state of the albumin present in human plasma can be achieved.
    Type: Application
    Filed: May 28, 2015
    Publication date: December 3, 2015
    Inventors: Juan Ignacio Jorquera Nieto, Ana Maria Ortiz Fernandez, Montserrat Costa Rierola